Oncotarget

Epigenetic Silencing of TRAIL-R2 Is Linked to Aggressive Features in Breast Cancer

14:04

Cancer cells often survive by disrupting the molecular pathways that normally eliminate damaged or abnormal cells. One of these pathways is apoptosis, a tightly controlled form of programmed cell death. New research suggests that an apoptosis-related receptor called TRAIL-R2 is frequently reduced in breast tumors and that epigenetic changes affecting its gene could contribute to this loss of…